U.S. Stock News

NYSE:BX
NYSE:BXCapital Markets

Blackstone (BX) Stock Looks Fully Priced After A 57% Run

Blackstone stock has delivered a strong 57.4% gain over the past three years, yet the current checks suggest investors are paying a premium to the latest intrinsic value estimate and to traditional valuation multiples. Over the past three years, Blackstone has returned 57.4%, which puts extra focus on whether that share price performance is still supported by fundamentals. Recent activity around AI data center investments and the extended TXNM Energy merger process can influence expectations...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Madrigal Pharmaceuticals (MDGL) Stock May Look Cheap On Sales But Risky On Cash Flow

Madrigal Pharmaceuticals stock has pulled back in recent weeks after a very strong multi year run, which leaves investors asking whether the current price still looks attractive based on the broader valuation checks. Over the past 5 years the share price has delivered a very large gain of about 5.4x, which means even small changes in expectations can now matter much more for valuation. Future expectations for Madrigal Pharmaceuticals often hinge on how successfully it can convert its...
NYSE:DCO
NYSE:DCOAerospace & Defense

The Bull Case For Ducommun (DCO) Could Change Following Strong Q2 2026 Earnings Momentum - Learn Why

In the past quarter ended July 4, 2026, Ducommun Incorporated reported second-quarter sales of US$224.49 million and net income of US$20.40 million, with diluted earnings per share from continuing operations of US$1.31, all higher than the same period a year earlier. Over the first six months of 2026, Ducommun’s sales of US$433.51 million and net income of US$30.32 million indicate a marked improvement in profitability and earnings per share compared with the prior-year period. With this...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Why Is Ionis Pharmaceuticals (IONS) Pushing RG-6299 Into A Pivotal Phase III Trial?

Ionis Pharmaceuticals (NasdaqGS: IONS) and partners Roche and Chugai are advancing RG-6299, an antisense therapy for IgA nephropathy, into a pivotal global Phase III trial. The program targets a major unmet medical need in IgA nephropathy, a chronic kidney disease with limited treatment options. The collaboration structure brings together Ionis' antisense platform with Roche and Chugai's development and commercialization capabilities. Successful Phase III results could support future...
NasdaqGS:LULU
NasdaqGS:LULULuxury

lululemon athletica (LULU) Is Down 5.3% After Softer Outlook and Legal Scrutiny - Has The Bull Case Changed?

Lululemon Athletica has recently faced weaker full-year earnings guidance, internal operational challenges, and legal scrutiny over reference pricing, even as it expands its Like New resale program into Canada and continues to beat revenue expectations. This mix of softer profit outlook, legal risk, and resale-led ecosystem expansion is prompting investors to reassess how durable Lululemon’s margins and brand strength may be. Next, we’ll examine how softer earnings guidance and mounting...
NYSE:VG
NYSE:VGOil and Gas

Venture Global (VG) Stock Looks Below Fair Value While Earnings Stay Discounted

Venture Global stock has delivered a sharp year to date gain while the valuation checks still point to the shares looking inexpensive overall. This raises a clear question about how much of the recent optimism is already reflected in the price. The stock is up 101.7% year to date, which puts recent buyers in a strong position and invites a closer look at whether that pace is sustainable. Progress on large LNG projects and higher export volumes can support higher earnings expectations. At the...
NYSEAM:HYLN
NYSEAM:HYLNElectrical

3 Penny Stocks With Stronger Balance Sheets Worth A Closer Look

US 10 year yields are near multi month highs as investors respond to inflation concerns and heavy debt issuance. Higher yields can make it harder and more expensive for smaller companies to raise money, which is one reason many penny stocks struggle. The Financially Fit Penny Stocks screener filters for stronger balance sheets and healthier cash profiles. This article highlights three stocks from the screener that aim to balance growth potential with financial discipline. The stocks covered...
NasdaqGS:FSLR
NasdaqGS:FSLRSemiconductor

First Solar (FSLR) Stock Looks Like A Bargain Despite Its 133% Run

First Solar stock has produced a 132.9% return over the past 5 years, yet recent weakness and a fresh policy boost from U.S. tariffs leave investors weighing what the latest valuation signals really say about the current US$220.01 share price. A 132.9% gain over 5 years suggests long term holders in First Solar have already captured a substantial return, so any new position or add now hinges on whether the stock still offers a margin between price and value. The recent 15% U.S. tariff on...
NYSE:CVS
NYSE:CVSHealthcare

CVS Health (CVS) Adds Data Chief Teresa Heitsenrether To Board As Larry Robbins Exits

CVS Health (NYSE:CVS) appointed JPMorgan executive Teresa Heitsenrether to its board of directors. The change coincides with the departure of director Larry Robbins. Heitsenrether currently serves as Chief Data & Analytics Officer at JPMorgan, bringing deep experience in data, analytics and artificial intelligence to the CVS Health board. The board change aligns with CVS Health's focus on technology driven healthcare, integrated care and consumer health technology. Readers who want more...
NYSE:INVX
NYSE:INVXEnergy Services

Should Innovex’s 5 Million Share Offering and Offshore Pivot Require Action From Innovex International (INVX) Investors?

In August 2026, Innovex International, Inc. filed and completed a follow-on equity offering of 5,000,000 common shares, adding new equity capital but also increasing its share count. This capital raise arrives as Innovex is pursuing higher margin offshore and Subsea work, manufacturing consolidation and acquisitions aimed at improving profitability and returns. We’ll now explore how Innovex’s completed 5,000,000-share follow-on offering may reshape its previously outlined investment...
NYSE:BHE
NYSE:BHEElectronic

Benchmark Electronics (BHE) Slides with Sector Selloff Is Its Valuation Simply Tracking Market Mood?

Earlier this week, Benchmark Electronics was caught in a broad selloff that hit electronic component manufacturers and contract electronics makers across the sector, reflecting widespread investor concern rather than any new company-specific development. The move underscores how closely Benchmark’s shares can track wider sentiment toward the electronics manufacturing sector, with peer stocks experiencing similar pressure at the same time. We’ll now consider how this sector-wide downturn,...
NYSE:ELF
NYSE:ELFPersonal Products

Stronger Q1 Results And Higher 2027 Sales Outlook Might Change The Case For Investing In e.l.f. Beauty (ELF)

e.l.f. Beauty, Inc. recently reported first-quarter 2026 results showing sales of US$479.37 million and net income of US$66.60 million, and also raised its fiscal 2027 net sales outlook to a range of US$1.94 billion to US$1.97 billion, implying a higher expected growth rate than previously forecast. The combination of stronger-than-prior-year earnings and an upgraded multi-year sales outlook highlights how the company’s operations and demand trends are currently supporting management’s...
NYSE:OMC
NYSE:OMCMedia

Did Omnicom’s (OMC) Q2 Revenue Beat and Margin Miss Just Shift Its AI-Driven M&A Narrative?

In late July, Omnicom Group reported its Q2 FY2026 results, delivering revenue ahead of expectations but profitability that fell short of analyst forecasts, prompting mixed investor reactions in the days that followed. This combination of a top-line beat and weaker margins has sharpened the focus on how effectively Omnicom can convert its expanding capabilities into sustainable earnings quality. We’ll now examine how the revenue beat but softer profitability in Q2 may influence Omnicom’s...
NYSE:STWD
NYSE:STWDMortgage REITs

Starwood Property Trust (STWD), Why Is It Getting Attention Today?

Starwood Property Trust (STWD) has drawn investor attention after the board appointed long-time president Jeffrey F. DiModica as a director and Investment Committee member, while Jeffrey G. Dishner resigned from the board. See our latest analysis for Starwood Property Trust. At a share price of $16.24, Starwood Property Trust has seen its 30 day share price return fall 4.47% and its year to date share price return decline 11.83%. The 3 year total shareholder return of 14.06% contrasts with a...
NasdaqGS:NVMI
NasdaqGS:NVMISemiconductor

Nova (NasdaqGS:NVMI) Stock Stays Rich On Record Revenue And Q3 Outlook

Nova stock has delivered very strong gains over the past five years, yet current valuation checks and recent share price volatility point to a more mixed picture on whether the recent enthusiasm is fully backed up by fundamentals. NOVA has returned 309.0% over the past five years, which puts extra focus on whether today's price still leaves room for an attractive long term outcome. Record recent revenue and a positive outlook for future sales can support higher expectations, while any...
NasdaqGS:CENX
NasdaqGS:CENXMetals and Mining

Is Century Aluminum (CENX) Undervalued After Its Strong Second Quarter Earnings?

Century Aluminum earnings spark fresh focus on profitability Century Aluminum (CENX) has drawn investor attention after reporting second quarter 2026 earnings that moved from a net loss to net income of $249.3 million, alongside revenue of $752.1 million. See our latest analysis for Century Aluminum. The strong second quarter swing back to profit has come alongside a 1-year total shareholder return of 108.02%, even though the share price is currently around $45.66 and has recently pulled back...
NYSE:TPB
NYSE:TPBTobacco

US Canada Trade Talks Put These Cross Border Stocks In Focus

A sudden pause in planned 50% U.S. tariffs on about US$20b of Canadian imports has given cross border trade stocks a brief window of clarity, while talks over a wider deal keep headlines and prices on edge. That mix of relief and risk creates a short list of companies that could either benefit or be tested. This article walks through 3 such stocks and how this trade story could matter for your portfolio. The three stocks below are just a starting sample from this cross border trade theme. The...
NYSE:SCL
NYSE:SCLChemicals

Can Stepan (SCL) Trade At A Discount Without Looking Cheap?

Stepan stock has rebounded over the past year, yet longer term shareholders are still facing a large 5 year decline, and today the valuation checks suggest the shares no longer look obviously cheap or obviously expensive at around this level. Over the past 5 years Stepan has delivered a return that is down about 40%, which puts extra focus on whether the recent recovery is supported by the fundamentals. Future valuation may depend on how consistently Stepan converts revenue into cash flow,...
NasdaqGS:VNET
NasdaqGS:VNETIT

VNET Group (VNET) Stock Looks Like A Bargain Even As Broader Checks Stay Mixed

VNET Group has rewarded long term holders with a return of 118.6% over the past three years. However, the stock is currently down over the past year and screens as only a mixed value story rather than a straightforward bargain. Over three years, VNET Group has gained 118.6%, which puts recent share price weakness into context for anyone looking at the longer track record. The newly announced partnership with battery giant CATL may support expectations for larger scale, more energy efficient...
NYSE:BAH
NYSE:BAHProfessional Services

Booz Allen Hamilton Holding (BAH), Why Is Attention Building Now?

Booz Allen Hamilton Holding (BAH) has drawn fresh attention after recent share price moves, including a gain over the past month alongside declines over the past 3 months and year to date. See our latest analysis for Booz Allen Hamilton Holding. Booz Allen Hamilton Holding’s recent 16.18% 1 month share price return contrasts with a weaker year to date share price return and a 1 year total shareholder return that is also down. This suggests recent momentum is rebuilding after a tougher...
NasdaqGM:FUTU
NasdaqGM:FUTUCapital Markets

Futu (FUTU) Stock Looks Undervalued After Its 133% Three Year Return

Futu Holdings has had a mixed share price story over different time frames, yet both its intrinsic value estimate from the Excess Returns model and market multiples currently point to the stock trading at a discount to what the fundamentals suggest. Over the past 3 years, Futu Holdings has delivered a total return of 133.2%, which means long term holders have already seen a strong payoff despite more recent share price weakness. For the valuation to hold up, Futu Holdings may need to keep...
NYSE:SUN
NYSE:SUNOil and Gas

Is Sunoco (SUN) Turning Value Credentials Into a Stronger Motor Fuels Investment Story?

Sunoco LP recently presented at Citi’s 2026 Natural Resources Conference at Encore Las Vegas, highlighting its role in US motor fuels distribution and infrastructure. Fresh analyst commentary emphasizing Sunoco’s value credentials and relatively low valuation multiples has brought renewed attention to the partnership’s earnings outlook and fundamentals. Next, we’ll examine how this renewed focus on Sunoco’s value profile and earnings outlook could influence the company’s broader investment...
NasdaqGS:ADBE
NasdaqGS:ADBESoftware

Adobe (ADBE) Faces A Fresh Valuation Test Following Its Freemium AI Shift

Adobe (ADBE) is in focus after management pushed ahead with a freemium shift for its AI tools, pausing price hikes while still targeting long term annual recurring revenue growth and accepting slower near term gains. See our latest analysis for Adobe. Adobe's recent freemium pivot for AI tools and record quarterly revenue have come against a mixed backdrop. A 1 month share price return of 10.91% contrasts with a year to date share price decline of 21.05% and a 1 year total shareholder return...
NasdaqGS:CEG
NasdaqGS:CEGElectric Utilities

Constellation Energy (CEG) Could Be 24% Below Fair Value On Raised 2026 Guidance

Constellation Energy (CEG) has become a focus for investors after management raised its full year 2026 guidance, supported by long term power purchase agreements with Microsoft, Meta and Walmart that provide contracted revenue visibility. See our latest analysis for Constellation Energy. Despite the raised 2026 guidance and new long term contracts, Constellation Energy’s share price has pulled back from a recent high near US$412 to about US$266.83, with the year to date share price return...